BR112021011293A2 - Composição farmacêutica para prevenção ou tratamento de câncer compreendendo lactobacillus sakei wikim30 como ingrediente ativo - Google Patents

Composição farmacêutica para prevenção ou tratamento de câncer compreendendo lactobacillus sakei wikim30 como ingrediente ativo

Info

Publication number
BR112021011293A2
BR112021011293A2 BR112021011293A BR112021011293A BR112021011293A2 BR 112021011293 A2 BR112021011293 A2 BR 112021011293A2 BR 112021011293 A BR112021011293 A BR 112021011293A BR 112021011293 A BR112021011293 A BR 112021011293A BR 112021011293 A2 BR112021011293 A2 BR 112021011293A2
Authority
BR
Brazil
Prior art keywords
active ingredient
lactobacillus sakei
pharmaceutical composition
preventing
treating cancer
Prior art date
Application number
BR112021011293A
Other languages
English (en)
Inventor
Hak Jong Choi
Mi Sun Yun
Original Assignee
Korea Food Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Food Res Inst filed Critical Korea Food Res Inst
Priority claimed from PCT/KR2019/016627 external-priority patent/WO2020122476A1/ko
Publication of BR112021011293A2 publication Critical patent/BR112021011293A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/50—Feeding-stuffs specially adapted for particular animals for rodents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/179—Sakei
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81—Aquaculture, e.g. of fish
    • Y02A40/818—Alternative feeds for fish, e.g. in aquacultures

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

composição farmacêutica para prevenção ou tratamento de câncer compreendendo lactobacillus sakei wikim30 como ingrediente ativo. se refere a um novo lactobacillus sakei wikim30 (no de acesso kccm11878p) isolado de kimchi e uma composição compreendendo o mesmo como um ingrediente ativo. lactobacillus sakei wikim30 de acordo com a presente invenção apresenta excelente atividade anticancerígena em modelos animais nos quais uma célula cancerígena é transplantada, e linhagens celulares cancerígenas, e, portanto, pode ser proveitosamente usada como uma composição em uso no tratamento, prevenção ou melhora de câncer de humanos ou animais.
BR112021011293A 2018-12-10 2019-11-28 Composição farmacêutica para prevenção ou tratamento de câncer compreendendo lactobacillus sakei wikim30 como ingrediente ativo BR112021011293A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20180158674 2018-12-10
KR1020190082026A KR102136772B1 (ko) 2018-12-10 2019-07-08 락토바실러스 사케아이 wikim30을 유효성분으로 포함하는 암의 예방 또는 치료용 약학 조성물
PCT/KR2019/016627 WO2020122476A1 (ko) 2018-12-10 2019-11-28 락토바실러스 사케아이 wikim30을 유효성분으로 포함하는 암의 예방 또는 치료용 약학 조성물

Publications (1)

Publication Number Publication Date
BR112021011293A2 true BR112021011293A2 (pt) 2021-11-23

Family

ID=71143385

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021011293A BR112021011293A2 (pt) 2018-12-10 2019-11-28 Composição farmacêutica para prevenção ou tratamento de câncer compreendendo lactobacillus sakei wikim30 como ingrediente ativo

Country Status (9)

Country Link
US (1) US20220062355A1 (pt)
EP (1) EP3895719A4 (pt)
JP (1) JP2022534150A (pt)
KR (1) KR102136772B1 (pt)
CN (1) CN113164536A (pt)
AU (1) AU2019396986A1 (pt)
BR (1) BR112021011293A2 (pt)
CA (1) CA3122124A1 (pt)
SG (1) SG11202106163RA (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220094155A (ko) 2020-12-28 2022-07-05 주식회사 리스큐어바이오사이언시스 락토바실러스 사케아이 균주 유래 나노소포를 유효성분으로 포함하는 암의 예방 또는 치료용 약학 조성물
WO2022145902A1 (ko) * 2020-12-28 2022-07-07 주식회사 리스큐어바이오사이언시스 락토바실러스 사케아이 균주 유래 나노소포를 유효성분으로 포함하는 암의 예방 또는 치료용 약학 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2886130B2 (ja) * 1996-03-18 1999-04-26 全国農業協同組合連合会 抗腫瘍剤
KR100574527B1 (ko) * 2003-02-24 2006-04-27 주식회사 프로바이오닉 면역활성이 높고 항암효과 및 유해 미생물 증식 억제활성이 뛰어난 신규 내산성 락토바실러스 사케이 Probio-44
KR100479719B1 (ko) * 2005-01-29 2005-03-31 주식회사 프로바이오닉 유해 병원성 미생물 생육 억제능 및 항알레르기성을 갖는 신규 내산성 락토바실러스 사케이 Ｐｒｏｂｉｏ-65
KR20120100608A (ko) * 2011-03-04 2012-09-12 주식회사 알엔에이 면역관련 및 염증성 질환의 예방 및 치료 활성을 갖는 신규한 락토바실러스 사케이(Ｌａｃｔｏｂａｃｉｌｌｕｓ ｓａｋｅｉ) Ｋ101
WO2013008803A1 (ja) * 2011-07-11 2013-01-17 国立大学法人 熊本大学 発酵能を有する細菌を用いた多能性細胞の製造方法
KR101287120B1 (ko) 2011-10-28 2013-07-17 대상에프앤에프 주식회사 락토바실러스 플란타륨 ｄｓｒ ｃｋ10또는 락토바실러스 플란타륨 ｄｓｒ ｍ2를 유효성분으로 함유하는 암 치료용 조성물
KR20150068061A (ko) 2013-12-11 2015-06-19 부산대학교 산학협력단 항암활성이 우수한 기능성 김치 및 그 제조방법
JP6302239B2 (ja) * 2013-12-20 2018-03-28 株式会社エイ・エル・エイ 抗腫瘍剤及びその製造方法
AU2016270750B2 (en) * 2015-06-01 2022-06-16 The University Of Chicago Treatment of cancer by manipulation of commensal microflora
KR101678317B1 (ko) * 2015-09-01 2016-11-21 한국식품연구원 김치 유산균 락토바실러스 사케아이를 유효성분으로 포함하는 아토피 피부염 치료용 약학 조성물

Also Published As

Publication number Publication date
KR20200070980A (ko) 2020-06-18
JP2022534150A (ja) 2022-07-28
CN113164536A (zh) 2021-07-23
AU2019396986A1 (en) 2021-07-22
CA3122124A1 (en) 2020-06-18
SG11202106163RA (en) 2021-07-29
EP3895719A1 (en) 2021-10-20
KR102136772B1 (ko) 2020-07-23
EP3895719A4 (en) 2022-09-07
US20220062355A1 (en) 2022-03-03
EP3895719A9 (en) 2022-08-17

Similar Documents

Publication Publication Date Title
BR112021011289A2 (pt) Composição farmacêutica para prevenção ou tratamento de câncer compreendendo weissella cibaria wikim28 como ingrediente ativo
PH12019500521A1 (en) Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer
CL2020002146A1 (es) Derivados de n-(fenil)-2-(fenil)pirimidina-4-carboxamida y compuestos relacionados como inhibidores hpki para tratar el cáncer.
PH12017501611A1 (en) Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
BR112017011923A2 (pt) bactéria modificada para tratar doenças associadas com hiperamonemia
UY37606A (es) 2-heteroaril-3-oxo-2,3-dihidropiridazin-4-carboxamidas
MX2021001558A (es) Inhibidores de itk de pirrolopirimidina.
BR112013027609A2 (pt) bactérias bacillus para uso no tratamento e prevenção de infecção em animais aquáticos
BR112020009655A8 (pt) Anticorpo, usos de um anticorpo e uso de uma combinação farmacêutica
BR112016019592A8 (pt) Composto, uso de um composto, e, composição farmacêutica
BR112022001415A2 (pt) Agentes interleucina-2 e os usos dos mesmos
BR112017008184A2 (pt) composições e linhagem
MX2019014772A (es) Formulaciones en gel de bisfosfocinas y usos de estas.
BR112021011293A2 (pt) Composição farmacêutica para prevenção ou tratamento de câncer compreendendo lactobacillus sakei wikim30 como ingrediente ativo
CA2902116C (en) Pyrrolopyridine derivatives and their use as inhibitors of ssao activity
PH12020551573A1 (en) Pharmaceutical compositions for inhibiting inflammatory cytokines
MX2018008903A (es) COMPOSICIONES Y METODOS DE USO DE ß-HIDROXI-ß-METILBUTIRATO (HMB) PARA MODULAR AUTOFAGIA Y LIPOFAGIA.
MX2023003677A (es) Inhibidores de hidroxiesteroide 17beta- deshidrogenasa 13 (hsd17b13) y usos de estos.
MX2023003678A (es) Inhibidores de hidroxiesteroide 17beta- deshidrogenasa 13 (hsd17b13) y usos de estos.
CL2021001656A1 (es) Compuestos de imidazopiridina e imidazopiridina y sus usos.
BR112013024909A2 (pt) composto, composição farmacêutica, método para o tratamento, prevenção ou melhoria de um ou mais sintomas de desordem, doença, ou condição mediada por pi3k, e método para modular a atividade enzimática de pi3k
MX2023003675A (es) Inhibidores de hidroxiesteroide 17beta-deshidrogenasa 13 (hsd17b13) y usos de estos.
PH12019501439A1 (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
PH12019501642A1 (en) Novel compounds and their use in the treatment of schistosomiasis